ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $65,000 | -30.1% | 11,790 | +2.3% | 0.00% | – |
| Q4 2017 | $93,000 | -33.1% | 11,521 | -13.6% | 0.00% | – |
| Q3 2017 | $139,000 | -4.1% | 13,331 | +0.4% | 0.00% | – |
| Q2 2017 | $145,000 | +31.8% | 13,279 | -0.2% | 0.00% | – |
| Q1 2017 | $110,000 | +18.3% | 13,311 | +0.1% | 0.00% | – |
| Q4 2016 | $93,000 | +36.8% | 13,303 | +0.3% | 0.00% | – |
| Q3 2016 | $68,000 | -13.9% | 13,265 | +0.1% | 0.00% | – |
| Q2 2016 | $79,000 | +43.6% | 13,257 | +10.4% | 0.00% | – |
| Q1 2016 | $55,000 | +14.6% | 12,007 | +12.5% | 0.00% | – |
| Q4 2015 | $48,000 | +26.3% | 10,674 | -18.7% | 0.00% | – |
| Q1 2015 | $38,000 | -24.0% | 13,128 | +16.0% | 0.00% | – |
| Q4 2014 | $50,000 | -57.3% | 11,318 | -49.2% | 0.00% | – |
| Q2 2014 | $117,000 | +44.4% | 22,259 | +13.9% | 0.00% | – |
| Q1 2014 | $81,000 | +84.1% | 19,540 | +29.4% | 0.00% | – |
| Q4 2013 | $44,000 | +22.2% | 15,099 | +6.3% | 0.00% | – |
| Q3 2013 | $36,000 | +44.0% | 14,203 | +16.6% | 0.00% | – |
| Q2 2013 | $25,000 | – | 12,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |